Using purified B cell from a relative large cohort, the present study demonstrates that SLE B cells mount a largely normal, if not diminished, response to TLR7 and TLR9 signaling in terms of cell proliferation and antibody production. The gene discussed is TLR7; the disease is systemic lupus erythematosus.